Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

61.14
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
46.01
Today|||52-Week Range
66.10
+4.62%
Year-to-Date
GOP Tax Fix Could Zero Out Orphan Drug Tax Credit
8:04am / TheStreet.com - Paid Partner Content
Nektar/Bristol-Myers' Combo Trial Positive in Phase I/II
Nov 13 / Zacks.com - Paid Partner Content
J&J Seeks Darzalex's Label Expansion in First-Line Setting
Nov 22 / Zacks.com - Paid Partner Content
Seattle Genetics' Adcetris Gets FDA Nod for Label Expansion
Nov 13 / Zacks.com - Paid Partner Content
Celldex (CLDX) Initiates Phase II Study on Cancer Candidate
Nov 20 / Zacks.com - Paid Partner Content
Merck KGaA (MKGAF) Q3 Earnings Decline Y/Y, Revenues Flat
Nov 10 / Zacks.com - Paid Partner Content
Pfizer's Cancer Drug Sutent Gets FDA Nod for Label Expansion
Nov 17 / Zacks.com - Paid Partner Content
Pharma ETFs Down Post Q3 Earnings
Nov 09 / Zacks.com - Paid Partner Content
Archford Capital Strategies, LLC Buys Vanguard S&P 500, British American Tobacco PLC,...
Nov 17 / GuruFocus News - Paid Partner Content
Buffalo Wild Wings jumps on hopes of rebound
Oct 26 / FT.com - Paid Partner Content
Cypress Wealth Advisors LLC Buys Bristol-Myers Squibb Company, DowDuPont Inc, iShares...
Nov 16 / GuruFocus News - Paid Partner Content
Earnings overload; Wild for Wild Wings; ECB watch
Oct 26 / CNNMoney.com
LabCorp Reports New Use of Agilent's Cancer Diagnostic Test
Nov 16 / Zacks.com - Paid Partner Content
Alzheimer's immunotherapy boosted by AbbVie deal
Oct 24 / FT.com - Paid Partner Content
Pharma Stock Roundup: FDA Nod for AstraZeneca Severe Asthma Drug, Bayer Signs Deal wi...
Nov 16 / Zacks.com - Paid Partner Content